Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 943k | 1.62 |
| 2025-06-30 | $915k | 710k | 1.29 |
| 2025-03-31 | $822k | 712k | 1.16 |
| 2024-12-31 | $813k | 761k | 1.07 |
| 2024-09-30 | $3.5M | 3.0M | 1.17 |
| 2024-06-30 | $3.0M | 2.8M | 1.08 |
| 2024-03-31 | $5.5M | 5.8M | 0.94 |
| 2023-12-31 | $7.5M | 7.6M | 0.99 |
| 2023-09-30 | $7.0M | 7.6M | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1